| Execution period | 2 years |
|---|
BSE filing, NSE: CCL. Summary written from the filing by ALFA Finder's alert engine.
CCL Products India Ltd: key numbers
- Share price
- ₹938.50
- Market cap
- ₹12,532 Cr
- Revenue (annual)
- ₹4,457 Cr
- Net profit (annual)
- ₹388.1 Cr
- P/E (TTM)
- 27.1×Sector 26.2×
- Promoter holding
- 46.16%+0.02% QoQ
- FII holding
- 12.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from CCL Products India Ltd
All →CCL Products India Earnings Call Transcript: Key Takeaways
Solid double-digit volume growth persists, but falling coffee prices are curbing value gains despite robust bottom-line expansion.
- Call
- Guides 15% growth
CCL Products India Management Change
CCL Products appointed Mr. Kallepally Bharath Kumar as Company Secretary and Compliance Officer, effective November 15, 2026, following Ms. Sridevi Dasari's resignation.
CCL Products India Other Announcement
CCL Products (India) Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. The document details the company's current promoter and public shareholding.
CCL Products India Board Meeting Date
CCL Products (India) Ltd will hold a Board Meeting on October 15, 2026, to approve the financial results for the quarter and half-year ended September 30, 2026.
CCL Products India Employee Stock Options
CCL Products (India) Limited announced the exercise of 2,100 equity shares by employees under its 2022 ESOP scheme. The exercise price was Rs. 2 per share.
CCL Products India Employee Stock Options
CCL Products (India) Limited allotted 6,785 equity shares to eligible employees under its Employee Stock Option Scheme – 2022.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date